UK Regulators Propose Blocking $1.2B Illumina, PacBio Deal

Oct 24, 2019

|

NEW YORK – Regulators in the UK have proposed blocking Illumina's $1.2 billion acquisition of Pacific Biosciences in an effort to preserve competition in the sequencing market in that country, as well as globally.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Treatment for Rapid Aging

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

AstraZeneca, Oxford Announce Results Suggesting High Efficacy of Vaccine

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

Criticism Leads to Review of Paper

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

PLOS Papers on SARS-CoV-2 Phylogenies, Swiss Influenza Spread, Infant Meningitis in Ethiopia

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.

Featured White Papers

Epigenetics & DNA Methylation

Protein Biomarkers that Identify Responders and Non-Responders to Immunotherapy for Malignant Melanoma

Planning Your Lab-Developed Test Validation Experiments

Validation of NGS-Based Laboratory-Developed Testing

Dec

02

Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec

03

Featured Webinar

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Recent work by many investigators has discovered that over the course of aging, hematopoietic stem cells (HSCs) commonly undergo clonal expansion.

Dec

10

Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology.

Menu

UK Regulators Propose Blocking $1.2B Illumina, PacBio Deal

To read the full story....

Breaking News

Agilent Q4 Revenues Rise 8 Percent

Novellus, Tempus Partner to Enroll Patients in BRAF Inhibitor Clinical Trial Program

Scope Fluidics Secures €6.2M Supporting Rapid MDx

Rare Variant Study Suggests Blood Pressure Traits May Have Ties to Development, Heart Conditions

Correlia Biosystems Closes $7M Series A Round

Twist Bioscience Fiscal Q4 Revenues More Than Double

The Scan

Treatment for Rapid Aging

AstraZeneca, Oxford Announce Results Suggesting High Efficacy of Vaccine

Criticism Leads to Review of Paper

PLOS Papers on SARS-CoV-2 Phylogenies, Swiss Influenza Spread, Infant Meningitis in Ethiopia

Featured White Papers

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Leveraging Multi-Omic Approaches to Understand Disease Stem Cells in Myeloid Malignancies

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

What's Popular?

Broad Institute DepMap Project Could Lead to Development of New Cancer Drugs

Increased Adoption of Whole-Genome Sequencing Testing Hinges on Acceptance by Payors, Providers

Burning Rock Adds New Data Supporting Cancer Screening Liquid Biopsy, Automated NGS Products

Twist Bioscience Plots Continued Growth With NGS Product Push Into Ag-Bio, Cancer Dx

Three Investment Banks Initiate Coverage of Biodesix

Sponsorships